1. Home
  2. CLDX vs NBHC Comparison

CLDX vs NBHC Comparison

Compare CLDX & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • NBHC
  • Stock Information
  • Founded
  • CLDX N/A
  • NBHC 2009
  • Country
  • CLDX United States
  • NBHC United States
  • Employees
  • CLDX N/A
  • NBHC N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NBHC Major Banks
  • Sector
  • CLDX Health Care
  • NBHC Finance
  • Exchange
  • CLDX Nasdaq
  • NBHC Nasdaq
  • Market Cap
  • CLDX 1.3B
  • NBHC 1.4B
  • IPO Year
  • CLDX 2008
  • NBHC 2012
  • Fundamental
  • Price
  • CLDX $21.35
  • NBHC $37.06
  • Analyst Decision
  • CLDX Buy
  • NBHC Hold
  • Analyst Count
  • CLDX 9
  • NBHC 5
  • Target Price
  • CLDX $50.00
  • NBHC $46.80
  • AVG Volume (30 Days)
  • CLDX 1.0M
  • NBHC 190.8K
  • Earning Date
  • CLDX 08-07-2025
  • NBHC 07-22-2025
  • Dividend Yield
  • CLDX N/A
  • NBHC 3.13%
  • EPS Growth
  • CLDX N/A
  • NBHC N/A
  • EPS
  • CLDX N/A
  • NBHC 2.89
  • Revenue
  • CLDX $7,559,000.00
  • NBHC $389,883,000.00
  • Revenue This Year
  • CLDX N/A
  • NBHC $11.81
  • Revenue Next Year
  • CLDX N/A
  • NBHC $6.78
  • P/E Ratio
  • CLDX N/A
  • NBHC $12.82
  • Revenue Growth
  • CLDX 24.49
  • NBHC N/A
  • 52 Week Low
  • CLDX $14.40
  • NBHC $32.83
  • 52 Week High
  • CLDX $47.00
  • NBHC $51.76
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 59.74
  • NBHC 52.29
  • Support Level
  • CLDX $19.25
  • NBHC $36.02
  • Resistance Level
  • CLDX $20.56
  • NBHC $36.82
  • Average True Range (ATR)
  • CLDX 1.13
  • NBHC 0.64
  • MACD
  • CLDX 0.04
  • NBHC -0.05
  • Stochastic Oscillator
  • CLDX 97.22
  • NBHC 52.47

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp is a bank holding company. It provides various banking products and financial services to commercial, business, and consumer clients in the United States. The company offers deposit products including checking accounts, savings accounts, money market accounts, and other deposit accounts, including fixed-rate and fixed-maturity time deposits. It also provides commercial and industrial loans and leases. In addition, it offers treasury management solutions comprising online and mobile banking, commercial credit cards, wire transfers, automated clearing house, and electronic bill payments.

Share on Social Networks: